Specialty Enzymes Market Size, Share & Trends Analysis growing at a CAGR of 6.6% from 2025 to 2030

The global specialty enzymes market size was valued at USD 6.05 billion in 2024 and is projected to reach USD 8.89 billion by 2030, growing at a CAGR of 6.6% from 2025 to 2030. The growth of the product market is attributed to the growing prevalence of chronic diseases such as cancer and rheumatoid arthritis.

Key Market Trends & Insights

  • North America specialty enzymes market dominated the global market with the largest revenue share of 41.9% in 2024.
  • The U.S. specialty enzymes market held the largest share in 2024, owing to increased demand for specialty enzymes in pharmaceuticals and diagnostics.
  • By product, the carbohydrase segment dominated the market with the largest revenue share of 37.6% in 2024.
  • By application, the pharmaceutical segment held the largest revenue share in 2024.
  • By source, the microorganisms segment accounted for the largest market share in 2024.

Market Size & Forecast

  • 2024 Revenue: USD 6.05 Billion
  • 2030 Projected Market Size: USD 8.89 Billion
  • CAGR (2025-2030):6.6%
  • North America: Largest market in 2024
  • Asia-Pacific: Fastest growing market

Request Free Sample Report: https://www.grandviewresearch.com/industry-analysis/specialty-enzymes-market/request/rs1

Furthermore, the expansion of food industries drives the demand for specialty enzymes. The enzymes such as lipases, amylases, proteases, rennet, pectinases, invertases, cellulases, and glucose oxidase play a vital role in the food processing industry. However, the complexities in biosimilar development may hinder the market’s growth. Utilizing specialty enzymes provides swift and effective solutions to various challenges, contributing to market expansion. These enzymes are widely used in diagnostic methods, including DNA modification and sequencing. The anticipated decline in the costs of DNA modification and sequencing is expected to drive enzyme demand in research, biotechnology, and medical applications. Moreover, the aging population in affluent countries is likely to increase the need for specialty enzymes in healthcare.

The development of innovative diagnostic methods, increasing adoption of enzymes in healthcare, and ongoing technological advancements are key drivers of global market growth. However, a major challenge is the limited consumer awareness of the benefits of specialty enzymes.

Legal and ethical concerns and low consumer awareness, particularly in emerging economies, also threaten market growth. Nevertheless, the rising rate of industrialization and adoption of advanced technologies in the pharmaceutical sector across emerging markets are expected to create future opportunities for market participants.

Increasing demand in pharmaceuticals and biotechnology fuels the specialty enzymes industry, driven by the need for efficient drug development, diagnostics, and therapeutic solutions. Breakthroughs in biotechnology and enzyme engineering improve enzyme performance, specificity, and stability, enabling customized applications across various industries. These advancements reduce production costs and enhance process efficiency, making specialty enzymes more attractive to manufacturers.

Specialty Enzymes Market Report Scope

Report Attribute

Details

Market size value in 2025

USD 6.45 billion

Revenue forecast in 2030

USD 8.89 billion

Growth Rate

CAGR of 6.6% from 2025 to 2030

Base year for estimation

2024

Historical data

2018 – 2023

Forecast period

2025 – 2030

Quantitative units

Revenue in USD billion and CAGR from 2025 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, application, source, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; Mexico; U.K.; Germany; France; Spain; Italy; China; Japan; India; South Korea; Indonesia; Australia; Brazil; Argentina; Saudi Arabia; and Türkiye.

Key companies profiled

Advanced Enzyme Technologies; Affymetrix Inc. (Thermo Fisher Scientific Inc.); Amano Enzyme Inc.; BBI Solutions; BASF; Codexis, Inc.; Nagase & Co., Ltd.; Life Technologies (Thermo Fisher Scientific Inc.); F. Hoffmann-La Roche Ltd; and Sanofi.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

 

Similar Posts